We investigate the extent to which antidepressant use among adolescents varies across racial and ethnic subgroups. Using a representative sample of U.S. adolescents, we find that non-Hispanic White adolescents are over twice as likely as Hispanic adolescents, and over five times as likely as non-Hispanic Black adolescents to use antidepressants. Results from a decomposition analysis indicate that racial/ethnic differences in characteristics, including household income, parental education, health insurance, and having a usual source of care explain between one half and two thirds of the gap in antidepressant use between Hispanics and non-Hispanic Whites. In contrast, none of the gap between Whites and Blacks in antidepressant use is explained by differences in observed characteristics. Further analysis suggests that there are large racial/ethnic differences in the extent to which behavioral and mental health problems prompt antidepressant use and that this may, in part, account for the large differences across race/ethnicity observed in our study.
Aday, L.A., & Andersen, R. ( 1975). Development of indices of access to medical care. Ann Arbor, MI: Health Administration Press.
2.
Aday, L.A., Flemming, G.V., & Andersen, R. ( 1984). Access to medical care in the U.S.: Who has it, who doesn’t . Chicago: Pluribus.
3.
Ai, C., & Norton, E. ( 2003). Interaction terms in logit and probit models. Economic Letters, 80, 123-129.
4.
American Academy of Child and Adolescent Psychiatry. ( 1998). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 37(Suppl.), 63S-83S.
5.
Andersen, R.M. ( 1968). Behavioral model of families’ use of health services . Chicago: Center for Health Administration Studies, University of Chicago.
6.
Andersen, R.M. ( 1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior , 36, 1-10.
7.
Andersen, R.M., & Newman, J.F. ( 1973). Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly , 51, 95-124.
8.
Bird, H.R., Andrews, H., Schwab-Stone, M., Goodman, S., Dulcan, M., Richters, J., et al. (1996). Global measures of impairment for epidemiologic and clinical use with children and adolescents. International Journal of Methods in Psychiatric Research, 6, 295-307.
9.
Bird, H.R., Shaffer, D., Fisher, P., Gould, M., Staghezza, B., Chen, J.Y., et al. (1993). The Columbia Impairment Scale (CIS): Pilot findings on a measure of global impairment for children and adolescents. International Journal of Psychiatric Research, 3, 167-176.
10.
Blinder, A. ( 1973). Wage discrimination: Reduced form and structural estimates . Journal of Human Resources, 8, 436-455.
11.
Breslau, J., Aguilar-Gaxiola, S., Kendler, K.S., Su, M., Williams, D., & Kessler, R.C. ( 2006). Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychological Medicine , 36, 57.
12.
Bridge, J.A., Iyengar, S., Salary, C., Barbe, R.P., Birmaher, B., Pincus, H.A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment . Journal of the American Medical Association, 297, 1683-1696.
13.
Bussing, R., Schoenberg, N., & Perwien, A. ( 1998). Knowledge and information about ADHD: Evidence of cultural differences among African-American and White parents. Social Science & Medicine, 46, 919-928.
14.
Bussing, R., Schoenberg, N.E., Rogers, K.M., Zima, B.T., & Angus, S. ( 1998). Explanatory models of ADHD: Do they differ by ethnicity, child gender or treatment status? Journal of Emotional and Behavioral Disorders, 6, 233-241.
15.
Chen, A.Y., & Chang, R.-K.R. (2002). Factors associated with prescription drug expenditures among children: An analysis of the medical expenditure panel survey. Pediatrics, 109, 728.
16.
Chen, A.Y., & Escarce, J.J. ( 2008). Family structure and the treatment of childhood asthma . Medical Care, 46, 174-184.
17.
Cohen, J. ( 1996). The Medical Expenditure Panel Survey: A national health information resource. Inquiry, 33, 373-389.
18.
Cohen, J. ( 1997). Design and methods of the Medical Expenditures Panel Survey household component. Rockville, MD: Agency for Health Care Policy and Research.
19.
Fairlie, R.W. ( 2005). An extension of the Blinder-Oaxaca decomposition technique to logit and probit models. Journal of Economic and Social Measurement, 30, 305-316.
20.
Garland, E.J. ( 2004). Facing the evidence: Antidepressant treatment in children and adolescents. Canadian Medical Association Journal, 170, 489.
21.
Glied, S., & Cuellar, A.E. ( 2003). Trends and issues in child and adolescent mental health . Health Affairs, 22(5), 39.
22.
Hahn, B.A. ( 1995). Children’s health: Racial and ethnic differences in the use of prescription medications. Pediatrics, 95, 727.
23.
Hammad, T.A., Laughren, T., & Racoosin, J. ( 2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339.
24.
Hudson, J.L., Miller, G.E., & Kirby, J.B. ( 2007). Explaining racial and ethnic differences in children’s use of stimulant medications. Medical Care, 45, 1068-1075.
25.
Hunkeler, E.M., Fireman, B., Lee, J., Diamond, R., Hamilton, J., He, C.X., et al. (2005). Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003. Journal of Child and Adolescent Psychopharmacology, 15, 26-37.
26.
Millman, M. ( 1993). Access to health care in America. Washington, DC: National Academies Press.
27.
Moeller, J., Stagnitti, M., Horan, E., Ward, P., Kieffer, N., & Hock, E. ( 2001). Outpatient prescription drugs: Data collection and editing in the 1996 Medical Expenditure Panel Survey (Pub. No. 01-0002). Rockville, MD: Agency for Healthcare Research and Quality.
28.
Oaxaca, R.L. ( 1973). Male-female wage differentials in urban labor markets . International Economic Review, 14, 693-709.
29.
Olfson, M., Shaffer, D., Marcus, S.C., & Greenberg, T. ( 2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry , 60, 978-982.
30.
Raghavan, R., Zima, B.T., Andersen, R.M., Leibowitz, A.A., Schuster, M.A., & Landsverk, J. ( 2005). Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology, 15, 97-106.
31.
Riolo, S.A., Nguyen, T.A., Greden, J.F., & King, C.A. ( 2005). Prevalence of depression by race/ethnicity: Findings from the National Health and Nutrition Examination Survey III. American Journal of Public Health, 95, 998-1000.
32.
Rowland, A.S., Umbach, D.M., Stallone, L., Naftel, A.J., Bohlig, E.M., & Sandler, D.P. ( 2002). Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina . American Journal of Public Health, 92, 231-234.
33.
Rust, K.F., & Rao, J.N.K. (1996). Variance estimation for complex surveys using replication techniques. Statistical Methods in Medical Research, 5, 283-310.
34.
Ryan, N.D. ( 2005). Treatment of depression in children and adolescents. Lancet, 366(9489), 933-940.
35.
Safer, D.J., Zito, J.M., & DosReis, S. ( 2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160, 438-449.
36.
U.S. Food and Drug Administration. (2005). Relationship between psychotropic drugs and pediatric suicidality: Review and evaluation of clinical data. Retrieved September 24, 2009 , from http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf
37.
Wolter, K.M. ( 1985). Introduction to variance estimation. New York: Springer-Verlag.
38.
Zito, J.M., Safer, D.J., DosReis, S., Gardner, J.F., Soeken, K., Boles, M., & Lynch, F. ( 2002). Rising prevalence of antidepressants among U.S. youths . Pediatrics, 109, 721-727.
39.
Zito, J.M., Safer, D.J., DosReis, S., & Riddle, M.A. ( 1998). Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 179-184.
40.
Zito, J.M., Safer, D.J., Zuckerman, I.H., Gardner, J.F., & Soeken, K. ( 2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56, 157-163.
41.
Zuvekas, S.H., & Fleishman, J.A. (2008). Self-rated mental health and racial/ethnic disparities in mental health service use. Medical Care, 46, 915-923.
